Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Gemcitabine for malignant mesothelioma: A phase II trial by the Cancer and Leukemia Group B.

Kindler HL, Millard F, Herndon JE, Vogelzang NJ, Suzuki Y, Green MR. Gemcitabine for malignant mesothelioma: A phase II trial by the Cancer and Leukemia Group B. Lung Cancer. 2001 Feb-Mar; 31(2-3):311-7.

View in: PubMed

collapse authors with profiles